fda statement bpc-157 not approved fda.gov July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026 FDA panel narrowly backs unapproved
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers BPC 157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT An FDA panel will consider whether to allow compounding pharmacies to manufacture certain peptides. Here's what to know about their safety and efficacy.
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


